StockMarketWire.com - Addiction specialist Indivior said Monday a US Court had granted the company a temporary restraining order, preventing Dr. Reddy's from launching its generic version of opioid addiction treatment Suboxone Film

This comes after shares of Indivior tumbled last week following reports that the FDA had approved Dr. Reddy's' generic version of Indivior's Suboxone Film, which could hurt Indivior's sales.

'We are pleased that the Court has granted our request for a temporary restraining order. This order will stop Dr. Reddy's launch activities before the court has had a chance to rule on the preliminary injunction motion,' said Shaun Thaxter, CEO.

'We will continue to pursue all legal avenues against Dr. Reddy's to protect our SUBOXONE Film patent estate.' Story provided by StockMarketWire.com